If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email email@example.com.
Please tell us what format you need. It will help us if you say what assistive technology you use.
This guidance document describes:
how to derive points of departure (POD) such as the Benchmark Dose (BMD) and potency estimates, such as the T25 and TD50
how to use these measures to estimate the relative potency of carcinogens